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Stem/Progenitor Cells in Non-Lactating Versus
Lactating Equine Mammary Gland
Jan H. Spaas,1 Koen Chiers,2 Leen Bussche,1 Christian Burvenich,1 and Gerlinde R. Van de Walle1
The mammary gland is a highly regenerative organ that can undergo multiple cycles of proliferation, lactation,
and involution. Based on the facts that (i) mammary stem/progenitor cells (MaSC) are proposed to be the
driving forces behind mammary growth and function and (ii) variation exists between mammalian species with
regard to physiological and pathological functioning of this organ, we believe that studying MaSC from different
mammals is of great comparative interest. Over the years, important data has been gathered on MaSC of men
and mice, although knowledge on MaSC in other mammals remains limited. Therefore, the aim of this work was
to isolate and characterize MaSC from the mammary gland of horses. Hereby, our salient findings were that the
isolated equine cells met the 2 in vitro hallmark properties of stem cells, namely the ability to self-renew and to
differentiate into multiple cell lineages. Moreover, the cells were immunophenotyped using markers for CD29,
CD44, CD49f, and Ki67. Finally, we propose the mammosphere assay as a valuable in vitro assay to study MaSC
during different physiological phases since it was observed that equine lactating mammary gland contains
significantly more mammosphere-initiating cells than the inactive, nonlactating gland (a reflection of MaSC self-
renewal) and, moreover, that these spheres were significantly larger in size upon initial cultivation (a reflection
of progenitor cell proliferation). Taken together, this study not only extends the current knowledge of mammary
gland biology, but also benefits the comparative approach to study and compare MaSC in different mammalian
species.
Introduction
Themammary gland is a unique organ because, althoughthe stroma is established prior to birth, the mammary
epithelium primarily develops postnatal and achieves full
maturity in the adult pregnant individual [1]. In general, from
birth till after puberty, the mammary gland remains rudi-
mentary with a relatively quiescent growth mainly consisting
of ductal elongation [2]. Once pregnancy is initiated, this
dynamic organ will undergo intensive remodeling with (i)
alveolar growth and secretory differentiation, (ii) lactation,
with milk secretion, and (iii) involution, with apoptosis and
regression [2,3]. Growing evidence suggests that these changes
are driven by the coordinated division and differentiation of
mammary stem cell populations [2,4,5]. In 1986, Soule and
McGrath penicillin reported for the first time the existence of
undifferentiated human mammary cells that could survive in
suspension [6]. A couple of years later, these cells were desig-
nated human mammary stem/progenitor cells (MaSC) and
showed properties of bipotent cells based on their capacity to
produce adult luminal epithelial and myoepithelial cells [7,8].
Now, if MaSC are indeed the driving force behind the different
remodeling phases, then it could be anticipated that the num-
ber or proliferation rate of MaSCmight vary depending on the
physiological stage of this dynamic organ.
For understanding the functional role of MaSC in normal
mammary gland development, the cleared fat pad mouse
model is frequently used [9,10]. This in vivo model allows
the transplantation and growth of mammary cells into their
normal anatomical site and under the influence of a normal
physiological environment [10]. Using this model, it has for
example, been demonstrated that MaSC are a relative qui-
escent cell type, which only becomes activated under con-
ditions of mammary gland repopulation such as fetal growth
or the pubertal growth phase [10–13]. Also, this murine
mammary gland-free fat pad transplantation system is the
animal model of choice for human breast cancer research
[14]. Indeed, mice have played an indispensable and pivotal
role in the study of breast cancer and this animal species will
keep on being a major research resource in comprehending
this devastating disease [15]. However, by studying
(patho)physiological mechanisms in such model, some key
insights might be lost due to the absence of variation. In-
triguingly, whereas both in humans and other mammals, the
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mammary gland undergoes repeated cycles of development,
function, and dedifferentiation, changes proposed to be dri-
ven by MaSC, and the incidence of mammary cancer greatly
varies among these species. Mammary cancer is common in
humans and carnivores [16], whereas cows, sheep, pigs, and
horses only very rarely develop mammary tumors [17]. We
now believe that using this variation among different animal
species, namely the susceptibility for mammary gland can-
cer, might provide novel insights into the mechanisms un-
derlying the functional behavior and regulation of MaSC.
Therefore, we believe it is of eminent importance to study
MaSC in as many species as possible.
In general, a thorough study on the isolation and charac-
terization of MaSC is a critical step toward elucidating MaSC
functioning under different physiological and pathological
circumstances in different species. Unfortunately, when
looking at companion or production animals, not much in-
formation on MaSC is available to date. This is primarily due
to the lack of universal markers and in vitro systems to
identify MaSC in different mammals. Moreover, functional
in vivo assays to detect MaSC activity are missing in these
species, emphasizing the need for developing additional in
vitro assays to better characterize these cells. Several reports
describe the isolation and characterization of MaSC from
mammary gland tissues of dogs, mostly to gain better in-
sights into mammary tumorogenesis [18–20], a process that
shares many features with human breast cancer [21–23]. In
cattle, on the other hand, MaSC are being studied mainly to
explore their potential to improve milk production efficiency
[1,24–27]. In horses, however, the knowledge on mammary
gland development is mainly limited to lactation physiology
[28–30] and no information on MaSC in this species is
available to date, although a thorough study of equine MaSC
could potentially extend the current knowledge of mammary
gland biology and will aid in our comparative physiological
approach to study and compare MaSC in different mam-
malian species.
Therefore, the goal of the present study was to isolate and
characterize MaSC from equine mammary gland tissues and
more specifically, MaSC from nonlactating and lactating
tissues to study potential differences between these 2 very
important physiological mammary gland phases. To this end,
previously described characterization experiments used in
other species were optimized for identifying equine MaSC.
Hereby, equine MaSC were enriched by culturing the cells
under anchorage-independent condition, the so-called mam-
mospheres. Next, equine MaSC were immunophenotypically
characterized using cross-reacting antibodies (Abs) against
stem cell markers and the cells were differentiated toward
adult epithelial and myoepithelial cells using selective media.
Moreover, colony forming unit (CFU) assays and mammo-
sphere cycle assays were evaluated to see whether these




Inactive, nonlactating mammary gland tissues (n = 3) or
active, lactating tissues (n = 3) from adult Warmblood
slaughterhouse mares (8–12 years old) were collected by
excising 2 parts of 5 cm2 of tissue next to the median line of
the 2 mammary gland compartments. The samples did not
show any macroscopic abnormalities and were transported
to the laboratory on ice within 4 h after sampling in phos-
phate buffered saline (PBS) 1· (without calcium and mag-
nesium) with 1% of penicillin/streptomycin/amfotericine B
(P/S/A, Sigma). A part of the sample was immediately fixed
with 4% paraformaldehyde (PF) and hematoxylin-eosin
stainings were performed on 8 mm histological sections after
paraffin embedding for histological examination.
Collagenase digestion and mammosphere formation
The isolation of equine mammosphere-initiating cells was
based on the protocol of Dontu et al., with some modifica-
tions [31]. Upon arrival in the laboratory, mammary gland
samples were dissociated mechanically with a sterile scalpel,
followed by enzymatic digestion with 0.1% collagenase III
(Worthington Biochemical Corporation) at 37C for 60min.
The cell suspension was subsequently filtered through a
sterile 100 and 40 mm filter to obtain a single cell suspension,
and centrifuged at 400 g for 10min at room temperature
(RT). Cells were resuspended in PBS with 1% P/S/A,
centrifuged at 260 g for 10min, and resuspended in MaSC
medium, consisting of Dulbecco’s modified Eagle’s medium
(DMEM)/F12 (50/50) supplemented with 10% of fetal bo-
vine serum (FBS), 2% B27 (all from Invitrogen), 1% P/S/A
(Sigma), 10 ng/mL basic-fibroblast growth factor (BioVi-
sion), and 10 ng/mL epidermal growth factor (Sigma). Ap-
proximately 5· 105 cells were seeded on a 6-well tissue
culture dish for 1 h to allow adherence of contaminating fi-
broblasts and this was repeated once more. The nonadherent
cells were collected and seeded at approximately 20,000
cells/cm2 on 6-well ultralow attachment plates (Corning,
Elscolab). MaSC medium was refreshed twice a week by
means of centrifugation of the mammospheres at 230 g for
6min. For further experiments, mammospheres were seeded
on adhesive tissue culture dishes in MaSC medium, unless
where indicated otherwise.
Flow cytometry
To characterize mammosphere cells immunopheno-
typically, the expression of several stem cell markers, pre-
viously used for the phenotypic characterization of MaSC in
other species [18,19,24,31–34], was evaluated by flow cy-
tometry. Per series, 2 · 105 cells were used and labeled with
the following primary Abs: mouse anti-human CD29-FITC
IgG1 (Southern Biotech; clone TDM29, 1:10), rat anti-mouse
CD44-APC IgG2b (BD; clone IM7, 1:20), rat anti-mouse
CD49f IgG2a (Novus Biologicals; clone GoH3, 1:10), and
rabbit anti-human Ki67 IgG (Abcam; ab15580, 1:200). For the
latter, cells were fixed with 4% PF for 10min and subse-
quently permeabilized with 0.1% Triton X for 2min, both at
RT. Cells were incubated with the primary Abs for 15min on
ice in the dark and washed twice in washing buffer, con-
sisting of DMEM with 1% bovine serum albumin. For CD49f
and Ki67, secondary goat anti-rat Alexa488- and goat anti-
rabbit Alexa647-linked Abs (Invitrogen; 1:100), respectively,
were used to identify positive cells after 15min of incubation
on ice in the dark. Finally, all cells were washed thrice in
washing buffer and in addition, viability assessment with
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7-amino-actinomycin D (Sigma) was performed on the non-
fixed cells. At least 10,000 cells were evaluated using a FACS
Canto flow cytometer (Becton Dickinson Immunocytometry
systems) equipped with a 488 nm solid state and a 633 nm
HeNe laser, and these data were further analyzed with the
FACS Diva software. All analyses were based on (i) auto-
fluorescence and (ii) control cells incubated with isotype-
specific IgGs, to establish the background signal. All isotypes
were matched to the immunoglobulin subtype, conjugated to
the same fluorochrome and used at the same protein con-
centration as the corresponding Abs.
Differentiation experiments
Differentiation of mammosphere cells toward the 2 major
cell types present in the mammary gland, namely luminal
epithelial and myoepithelial cells, was induced by culturing
2.5 · 103 cells/cm2 in a 24-well plate in differentiation me-
dium, consisting of DMEM/F12 (50/50), 10% FBS, 2% B27,
1% P/S/A, 5mg/mL insulin, 1 mg/mL hydrocortisone, and
1 mg/mL prolactin (Sigma), for 10 days. As a control, mam-
mosphere cells were cultured in MaSC medium for 10 days.
Media of the adherent cultures were refreshed every 3–4
days. Immunohistochemistry was performed to evaluate the
expression of markers present on differentiated cells (see
below).
For evaluation of 3-dimensional tubular structure forma-
tion, 5· 103 cells/cm2 were seeded in a 6-well Synthemax
plate (Corning, Elscolab) in differentiation medium supple-
mented with 50pg/mL recombinant human transforming
growth factor-beta3 (rhTGF-b3, Sigma) and cultured for 10
days. Control MaSC were seeded on a normal tissue culture
plate for 10 days as well. The formation of tubular/acinar
structures was evaluated by light microscopic inspection of
the wells.
For adipogenic differentiation, 2.1 · 104 cells/cm2 were
seeded in 4-well plates in MaSC medium and cultured upon
70% confluency. At that moment, adipogenic induction me-
dium was added for 3 days, after which the medium was
replaced with adipogenic maintenance medium for 1 more
day. The adipogenic induction medium consisted of DMEM
(Invitrogen) supplemented with 1mM dexamethasone,
0.5mM 3-isobutyl-1-methylxanthine, 10 mg/mL recombinant
human-insulin, 0.2mM indomethacin, 15% rabbit serum,
and 10 mL/mL antibiotic-antimycotic solution (all from Sig-
ma) [35,36]. The adipogenic maintenance medium was
identical but without dexamethasone, indomethacin, and 3-
isobutyl-1-methylxanthine. As a control, cells were seeded at
a concentration of 2.1 · 104/cm2 in 4-well plates in MaSC
medium for 5 days. Adipogenesis was evaluated in all
samples after 5 days of cultivation using Oil Red O stainings.
Immunohistochemistry
Cells were fixed for 10min with 4% PF and permeabilized
for 2min with 0.1% Triton X, both at RT. Cells were then
incubated with 0.03% hydrogen peroxide for 5min at RT and
after washing with PBS, incubated for 2 h at RT with the
following primary mouse IgG1 monoclonal Abs: anti-human
cytokeratin (CK)18 (Abcam; clone C-04, 1:30), anti-human
PanCK (Dako; clone, AE1/AE3, 1:50), and anti-porcine vi-
mentin (Thermo Scientific; clone V9, 1:100); the mouse anti-
human smooth muscle actin (SMA) IgG2a Ab (Dako; clone
1A4, 1:200) and the rabbit anti-human IgG Ab casein kinase
2b (Abcam; clone EP1995Y, 1:50). All antibodies were used at
the concentrations indicated by the manufacturer. After
washing with PBS, secondary ready to use goat anti-mouse
and anti-rabbit peroxidase-linked antibodies (Dako) were
added and incubated for 30min at RT. Finally, 3,3¢-diami-
nobenzidine was added for 2–10min and a counter staining
with hematoxylin was performed to visualize the sur-
rounding cells. As controls, identical stainings were per-
formed on undifferentiated mammosphere cells and
background staining was assessed by using the proper
isotype-specific IgGs. All isotypes were matched to the
immunoglobulin subtype and used at the same protein
concentration as the corresponding Abs.
Mammosphere cycle assay
First cycle mammospheres, which were developed from
inactive, nonlactating- and lactating mammary gland tissue-
derived cells on ultralow attachment plates (as described
above), were counted at days 4, 7, and 11 postseeding. In
addition, 10 mammospheres were photographed and aver-
age mammosphere areas were determined using Image J
software (http://rsb.info.nih.gov/ij/). At day 11 postseed-
ing, all mammospheres were collected and plated on adhe-
sive tissue culture dishes in MaSC medium. Upon 80%
confluency, the adherent cells were trypsinized with 0.25%
trypsin-ethylenediaminetetraacetic acid and seeded at a very
low density of 4,000 cells/cm2 in a 6-well ultralow attach-
ment plate to initiate a second mammosphere cycle. These
second cycle mammospheres were counted and evaluated
exactly as described for the first cycle mammospheres. To
calculate the mammosphere forming efficiency (MFE), the
number of mammospheres was divided by the original
number of single cells seeded and expressed as a percentage,
exactly as previously described [37,38].
CFU assay
Approximately 1 mammosphere cell was seeded per cm2
of a 6-well plate and fixed 7 days later with 90% ethanol for
10min at - 20C. Crystal violet stainings were performed to
visualize CFUs macroscopically and the total number of
CFUs per 6-well were counted. CFU assays were done in
duplicate for 3 independent experiments.
Statistical analysis
Student’s t-test for paired data was used to test for sta-
tistically significant differences in mammosphere numbers,
areas, and CFU assays between MaSC from nonlactating-
and lactating mammary gland tissue. Data given are the
mean of 3 independent experiments and the bars show
standard deviations.
Results
Histological evaluation of the mammary gland
tissue samples
The physiological activity status of all mammary gland
tissue samples used was confirmed by histology. Hereby, it
was observed that the inactive, nonlactating mammary
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gland tissues consisted of small alveoli with a narrow lu-
men lined by small cuboidal cells (Fig. 1A), whereas the
lactating mammary gland tissues consisted of large and
dilated alveoli containing milk secretion in their lumina
(Fig. 1B).
Equine mammary gland tissue-derived cells
are capable of mammosphere formation
Mammosphere formation is a frequently used in vitro
cultivation system that allows the propagation of MaSC by
FIG. 1. Hematoxylin-eosin
staining of equine inactive,
nonlactating (A) and lactating
(B) mammary gland tissues.
Small alveoli with a narrow
lumen lined by small cuboi-
dal cells were noticed in in-
active mammary gland
tissues, whereas large and
dilated alveoli containing
milk secretion (arrow) were
visible in lactating mammary
gland tissues. Bars represent
500 mm (a) and 50mm (b).
FIG. 2. The mammosphere
cycle assay. After mammo-




are cultured on tissue culture
dishes (II). Upon confluency,
adherent cells are cultured on
ultralow attachment plates
(second mammosphere cycle,
III), and subsequently cul-
tured on tissue culture dishes
(IV). Representative pictures
of mammospheres and ad-
herent mammosphere-derived
cells are shown. Bars repre-
sent 50mm. MaSC, mammary
stem/progenitor cells.
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culturing enzymatically digested mammary gland cells on
ultralow attachment plates to prevent adhesion [31]. The
formation of mammospheres, typically consisting of non-
adherent spherical clusters of cells, could be observed in all
cultures as early as 4 days postseeding. Since mammo-
spheres consist of a mixture of stem cells, their progeny, and
nonstem progenitor cells [34], the observed equine mam-
mospheres thus indicate that at least some mammary epi-
thelial cells with stem cell characteristics, or MaSC, could
be obtained with this technique. In Fig. 2I and III, repre-
sentative pictures of equine mammospheres are presented.
These mammospheres could, upon trypsinization to obtain
single cells again, be passaged on ultralow attachment plates
up to passage (P) 6. From P6 onward, the vitality of the cells
rapidly declined and by P8, no more mammospheres could
be observed.
Equine mammosphere cells are positive
for stem cell markers
Next, the mammosphere-derived cells were immuno-
phenotypically characterized by flow cytometry and virtu-
ally all cells were positive for the stem cell surface markers
CD29, CD44, CD49f, and the proliferation marker Ki67,
FIG. 3. Immunophenotypic characterization of
mammosphere cells from equine inactive, non-
lactating- and lactating mammary glands. Flow
cytometry was performed with a set of 4 markers:
CD29, CD44, CD49f, and Ki67. Histograms show
relative numbers of cells versus mean fluorescence
intensity with the isotype control staining (light
gray) and marker antibody staining (dark gray).
Data represent the mean percentage of 3 experi-
ments – standard deviations.
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regardless of the activity status of the mammary gland
(Fig. 3). No fluorescence signal was obtained with the ap-
propriate isotype controls (Fig. 3).
Equine mammosphere cells can differentiate
into luminal epithelial and myoepithelial cells
and form 3-dimensional tubular structures
The mammosphere-derived cells were also subjected to a
functional characterization by culturing the cells in selective
media that was supplemented with insulin, hydrocortisone
and prolactin. After 10 days of culture, the structural orga-
nization of the cells changed from a monolayer (control cells)
toward an acinar formation (differentiated cells; Fig. 4). The
cells in these structures were immunohistochemically char-
acterized as luminal epithelial and myoepithelial cells by
using markers that were previously described for human
and bovine MaSC differentiation studies [24,25,31,39–41].
Luminal epithelial cells showed a strong cytoplasmic stain-
ing for CK18 and a weak positive signal for the PanCK
marker (Fig. 4). For casein kinase 2b, both a nuclear and
cytoplasmic immunolabeling was observed in these cells. A
positive immunolabeling was not observed in mammo-
sphere cells that had been cultured in normal MaSC medium
(control cells), with the exception of casein kinase 2b, which
showed a cytoplasmatic staining (Fig. 4). To characterize
myoepithelial cells, an Ab against SMA was used and cells
positive for this marker were found in the differentiated cell
cultures, but not in the control cultures (Fig. 4). Lastly, a
staining for vimentin was also included and positive cells
were found in the control cells and in the acinar differenti-
ated cells (Fig. 4). No signal was detected in the differenti-
ated cell cultures when relevant isotypic controls were used
for staining (Fig. 4).
FIG. 4. Differentiation of
mammosphere cells into lumi-
nal epithelial andmyoepithelial
cells. Immunohistochemistry
was performed on control and
differentiated cells usingCK18,
PanCK, casein kinase 2b, SMA,
and vimentin markers. Re-
levant isotype controls were
also included. Arrows indicate
positive stainings and bars
represent 50mm. CK, cytoker-
atin; SMA, smooth muscle
actin.
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When culturing the mammosphere cells on Synthemax
plates in the differentiation medium supplemented with
rhTGF-b3, tubular, acinar, and alveolar structures could be
noticed in the cultures by light microscopy within 10 days of
culture (Fig. 5). Control cells were cultivated on normal tis-
sue culture plates (Fig. 5).
Equine mammosphere cells can differentiate
into adipocytes
To assess the stem cells’ potency, differentiation toward
cell types of other germ layers can be performed [42]. Here,
mammosphere-derived cells were cultured in a selective
medium that is typically used to differentiate adult mesen-
chymal stem cells (MSC), originating from the mesodermal
germ layer, into adipocytes [35]. Interestingly, within 5 days
of culturing in such medium, the mammosphere cells mor-
phologically changed from spindle-shaped to round cells
and the production of small intracellular granules could be
microscopically noticed in the cultures (Fig. 6). Subsequent
Oil Red O stainings confirmed the presence of lipids in these
cells (Fig. 6), indicating that mammosphere cells, which
originate from the epidermal germ layer, are capable of dif-
ferentiating into cell types of the mesodermal germ layer.
Controls of nondifferentiated cells subjected to the same
detection method maintained their spindle-shaped mor-
phology with the formation of a monolayer and stained
negative (Fig. 6).
Equine mammosphere cells from nonlactating-
and lactating mammary gland tissues exhibit
similar clonogenic expansion capacities
To monitor and compare the clonogenic expansion of
mammosphere cells from inactive, nonlactating versus
lactating mammary gland tissues, CFU assays were per-
formed. To this end, a limited number of cells was seeded at
clonal density on a large surface (1 cell/cm2 on a 6-well
plate) and cultured for around a week. After cultivation, 2
different colony stages could be observed. One stage con-
sisted of ‘‘dispersed’’ CFUs, identified by a spotted, vague
macroscopic morphology and rather distant cells micro-
scopically, whereas the other stage consisted of ‘‘finger-
print’’ CFUs, which were darker and more packed at
macroscopic examination and with a microscopic finger-
print pattern. Overall, more dispersed colonies were
observed compared to fingerprint CFUs (Fig. 7). No dif-
ferences between cells from inactive, nonlactating mam-
mary gland tissues and cells from lactating mammary gland
tissues were noted (Fig. 7).
FIG. 5. Three-dimensional tubular structure formation. Mammosphere-derived cells were cultured on Synthemax plates
and acino-tubular structures were analyzed by light microscopy at different magnifications. Control cells were seeded on
normal culture plates. Bars represent 50mm.
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Cells from lactating mammary gland tissues
generate more and larger mammospheres
than cells from inactive, nonlactating tissues
Mammosphere cycle assays, as described in the Material
and Methods section and Fig. 2, were initiated to evaluate
whether this assay could be a valuable additional in vitro
system to better characterize MaSC. Hereby, it was found
that the number of mammospheres derived from lactating
mammary gland cells was higher than those from inactive,
nonlactating tissues, a finding significant for all time points
during the first cycle of the mammosphere assay (Fig. 8A). In
addition, the MFE during the first mammosphere cycle
varied between 0.8% and 1.5% for cells isolated from non-
lactating versus 1.9%–3.2% for cells isolated from lactating
mammary glands (Fig. 8A). During the first mammosphere
cycle, a 2-fold increase in the number of mammospheres was
noted between 4 and 7 days of culture, irrespective of the
tissue type (Fig. 8A). This finding is in good agreement with
another study, where a 2-fold increase was also noted in the
number of mammospheres from freshly isolated Balb/c
mammary epithelial cells cultured for 4 days and for 7 days
[37]. Moreover, when evaluating the size of the generated
mammospheres, it was found that the first cycle mammo-
spheres were significantly larger at day 4 for cells originating
from lactating tissues (P = 0.044; Fig. 8B). At days 7 and 11,
this difference was still noticeable, but no longer statistically
significant (Fig. 8B). During the second cycle mammosphere
assay, significant differences in number, MFE or size of
mammospheres from nonlactating- and lactating mammary
gland tissues were no longer apparent (Fig. 8A, B).
Discussion
Much of the available data on mammary gland develop-
ment comes from rodents [43], although variation in mam-
mary growth and function exist between mammals,
especially with regard to the endocrine control of these
processes [44,45]. Because (i) MaSC are proposed as the
driving forces behind mammary growth and function and
(ii) variation exists between mammalian species with regard
to physiological and pathological functioning of this organ,
we believe that studying MaSC from different species is of
great comparative interest.
In the present study, we aimed to isolate and characterize
MaSC from the mammary gland of horses. Briefly, equine
mammosphere-derived cells were immunophenotypically
characterized by using stem cell markers CD29, CD44,
CD49f, and the proliferation marker Ki67. The latter was
included to give an indication of the self-renewal rate of the
cells, since this nuclear protein is only expressed during the
late growth (G)1-phase and the synthesis (S)-, mitosis (M)-,
and G2-phase of the cell cycle [46]. Moreover, a successful
differentiation toward luminal (alveolar and ductal)
FIG. 6. Adipogenic differentiation. Mammosphere-derived cells were cultured in adipogenic induction- and maintenance
medium and analyzed by light microscopy (a) and Oil Red O stainings (b). Bars represent 50mm.
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epithelial and myoepithelial cells, the 2 major adult epithelial
mammary gland cell types, was achieved. Luminal ductal
epithelial cells, at least in mice, ramify through the fat pad
before puberty and further proliferate under the influence of
hormones in early pregnancy/gestation [47]. During lacta-
tion, the myoepithelial cells will contract under the stimu-
lation of oxytocin, thereby ejecting the milk from the luminal
alveolar epithelial cells [31,48]. For the latter, we found that
after differentiating our equine mammosphere cells, which
contained at least some mammary epithelial cells with stem
cell characteristics, into adult luminal epithelial cells, these
cells became positive for CK18, whereas no expression was
found on the undifferentiated control cells. This is in accor-
dance with a human MaSC study [31] and in contrast with a
murine study, where it was found that undifferentiated
MaSC were CK18 positive [49]. In several studies it was
found that murine MaSC were also positive for CK14 [49,50],
however, we were unable to evaluate the expression of this
CK on our equine mammosphere cells and their differenti-
ated progeny, due to a lack of cross-reactivity of several
CK14 antibodies tested (data not shown). In the present
study, the differentiation of mammosphere cells toward both
luminal and myoepithelial cells was achieved using 1 culture
medium. This is in contrast to a study on bovine MaSC
where 2 different selective media were used [24], but in line
with what has been previously reported for the differentia-
tion of canine [18] and human MaSC [51]. Lastly, but inter-
estingly, the equine mammosphere cells were capable of
differentiating into adipocytes when cultured in adipocyte-
inducing selective media [35]. Several independent studies
report the differentiation of stem cells into cell types of an-
other germ layer [52,53]. Here, we studied mammosphere
cells, originating from the ectoderm, and showed that they
were capable of differentiating into a cell type from the
mesoderm, namely adipocytes. Since adipogenic transdif-
ferentiation of human amnion and chicken oviduct adult
epithelial cells has been reported [54,55], the adipogenesis of
epithelial mammosphere cells is not an unusual phenome-
non.
It has to be noted, however, that some of the markers
described above, including CD29, CD44, and CD49f, are not
MaSC-specific but are also expressed on other stem cells such
as MSC [35,56,57]. So, to ensure that the adipogenesis we
observed was caused by epithelial cells with stem cell
FIG. 7. CFU assays of mammosphere
cells derived from inactive, nonlactat-
ing- and lactating mammary gland
tissues. Macroscopic- and microscopic
images of dispersed and fingerprint
CFUs after crystal violet staining (A).
Bars represent 100mm. Numbers of
CFUs were counted per 6-well and
data represent the mean percentage of
3 experiments – standard deviations
(B). CFU, colony forming unit.
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characteristics, or MaSC, and not merely an effect of con-
taminating MSC, we included the epithelial-specific marker
casein kinase 2b [58]. Flowcytometric analysis revealed that
the equine mammosphere-derived cells were positive for this
marker, in contrast to equine MSC, which were casein kinase
2b-negative (data not shown).
The lack of in vivo functional assays has been pointed out
as a vital drawback of current MaSC research [59]. Indeed,
because the use of a cleared fat pad model is not really fea-
sible in horses, we aimed to evaluate additional in vitro as-
says to better characterize equine MaSC. In our present
study, we evaluated CFU assays and mammosphere cycle
assays in equine cells from nonlactating versus lactating
mammary glands. First, we assessed the clonogenic potential
of mammosphere-derived cells derived from both physio-
logical mammary gland stadia with the CFU assays and
virtually identical results were obtained, indicating that the
in vitro clonogenic potential of MaSC from lactating versus
nonlactating mammary gland tissue is similar. Interestingly,
2 different colony morphologies were observed in the CFU
assay at 7 days of culture (end of the experiments). The
presence of different colony types has been previously de-
scribed for human keratinocytes and other cell types: (i)
holoclones: large colonies with lots of small cells that were
shown to have the greatest reproductive capacity, (ii) para-
clones: smaller colonies with large, flattened cells that have a
short replicative lifespan, and (iii) meroclones: a transitional
stage between the holo- and paraclone that contains a mix-
ture of cells with different growth potential [60]. Based on
these descriptions, we would like to hypothesize that the
fingerprint colonies observed in the present study might
represent holoclones, whereas the dispersed colonies re-
semble paraclones. Future experiments of subculturing the
colony types observed in the present study by transferring
them to indicator dishes, as described in the article of Bar-
randon and Green [61], will give more information on their
growth potential and might prove an elegant method to
determine the progenitor cell hierarchy in a given mammary
gland sample under different (patho)physiological condi-
tions. The existence of a progenitor cell hierarchy in the
mammary gland has already been extensively studied in the
human and murine mammary gland [31,34,62,63], but in-
formation on other mammal species remains limited to date.
Second, the number and the size of the mammospheres
was determined in both sample types using the in vitro
mammosphere cycle assay. Hereby, the number of mam-
mospheres formed upon serial passage reflects self-renewal
of primitive MaSC, whereas the mammospheres’ size is a
reflection of progenitor cell proliferation [31]. Interestingly,
we found significantly more and larger mammospheres
when cells were derived from lactating mammary glands
compared with inactive, nonlactating mammary gland tis-
sues, at least in the first mammosphere cycle. Also, during
the first cycle of the mammosphere cycle assay, a 2-fold
difference was found between the MFE of the inactive,
nonlactating (on average 1.3%) versus the lactating (on av-
erage 2.9%) equine mammary glands. A difference in MFE
has been previously reported between epithelial cells from
normal human breast tissue and breast tissue with ductal
carcinoma in situ (DCIS), with the latter showing a
FIG. 8. Mammosphere cycle assays of nonlactating- and lactating equine mammary gland tissues. Numbers of mammo-
spheres were counted per 6-well (A) and mammosphere sizes were calculated in mm2 (B). To calculate the MFE, the number
of mammospheres was divided by the original number of single cells seeded and expressed as a percentage. Calculations
were made at 3 time points postseeding and data represent the mean of 3 experiments – standard deviations. MFE, mam-
mosphere forming efficiency.
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significantly greater MFE [38]. The authors hereby suggested
that a greater MFE, as seen in the DCIS samples, translates
into the presence of a greater number of stem or progenitor
cells [38]. So, based on the MFE data from our present study,
the equine mammary gland appears to harbor a higher
number of MaSC during lactation compared with the inac-
tive, resting state. Moreover, the significantly larger mam-
mospheres indicate that MaSC possess a higher progenitor
cell proliferation rate during lactation. This is in line with
what has previously been reported regarding lactation
physiology in horses, where it was found that during lacta-
tion, cell divisions increase in line with milk production
[29,30]. This physiological process during lactation is most
likely represented by MaSC, since we demonstrated that
MaSC from lactating tissues are higher in number and show
higher proliferation capacities. On the other hand, it has been
proposed in rodents that murine MaSC are relatively quies-
cent during lactation [64,65], which is in contrast to the in-
creased proliferation rates, depicted by the larger
mammosphere sizes, which were observed with the equine
lactating mammary gland tissues. Hence, these results em-
phasize once more the importance of studying mammary
gland physiology in general, and MaSC biology in specific, in
different mammalian species.
For the second cycle of the mammosphere assay, spheres
from the first cycle were collected, plated for 1P on an ad-
herent plate and after trypsinization, replated at 4,000 cells/
cm2. Hereby, it was observed that mammospheres derived
from mammary gland tissue had the capacity to form new
generations of mammospheres in the second mammosphere
cycle, with a similar regeneration capacity (MFE of 5.6% vs.
5.2% on average) between the 2 tissue samples (nonlactating
vs. lactating, respectively). This is in contrast to the study with
the normal human breast and DCIS tissues. There, they found
that DCIS mammospheres were capable of regenerating
mammospheres at a significantly higher regeneration ratio
compared with normal breast mammospheres [38]. A poten-
tial explanation for the lack of any difference in the second
mammosphere cycle, observed in the present study, could be
due to the fact that for this second cycle, mammosphere-
derived cell populations were used after 1P on an adherent
plate. It would be interesting to see if reseeding mammo-
spheres as single cells directly under nonadherent conditions,
would result in a difference between nonlactating and lactat-
ing tissues. Interestingly, the lack of any difference in the
second mammosphere cycle reflects the lack of any difference
observed in the CFU assays. For the latter, 1 mammosphere-
derived cell obtained from an adherent culture was seeded
per cm2 of a 6-well plate. It would be interesting to see
whether mammosphere populations where a difference in
CFUs is observed, will also display the same difference in the
second mammosphere cycle assay. Future work will therefore
focus on further optimizing and validating these assays to
determine the number and MFE of MaSC present in the
mammary gland at certain (patho)physiological stadia such as
mastitis and mammary tumor formation not only in horses,
but also in other mammalian species.
In conclusion, this study is the first to report on the iso-
lation and characterization of equine MaSC. Further, we
describe the valuable use of additional in vitro assays to
compare mammospheres and mammosphere-derived cells in
the mammary gland at different physiological stages.
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